European equities traded in the US as American depositary receipts were moving higher late Friday morning, rising 0.69% to 1,421.31 on the S&P Europe Select ADR Index. Despite the increase, the index remains marginally lower for the week.
From continental Europe, the gainers were led by biopharmaceutical company Cellectis (CLLS) and oil and gas company Eni (E), which climbed 10.2% and 4.1% respectively. They were followed by consumer goods company Unilever (UL) and telecommunications company Ericsson (ERIC), which were up 1.3% and 1.4% respectively.
The decliners from continental Europe were led by biopharmaceutical company DBV Technologies (DBVT) and semiconductor company Sequans Communications (SQNS), which fell 5.8% and 4% respectively. They were followed by 3D printer company Materialise (MTLS) and furniture maker Natuzzi (NTZ), which lost 4.8% and 2.2% respectively.
From the UK and Ireland, the gainers were led by biopharmaceutical companies Adaptimmune Therapeutics (ADAP) and TC Biopharm (TCBP), which increased by 3.8% each. They were followed by biopharmaceutical company NuCana (NCNA) and construction materials supplier CRH (CRH), which increased 3.6% and 2.4% respectively.
The decliners from the UK and Ireland were led by biopharmaceutical companies Akari Therapeutics (AKTX) and Biodexa Pharmaceuticals (BDRX), which dropped 3.5% and 2.5% respectively. They were followed by biopharmaceutical company Mereo BioPharma Group (MREO) and biotech firm Trinity Biotech (TRIB), which fell 2.3% and 1.7% respectively.
Comments